Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Akers Biosciences

(NASDAQ: AKER)
Add to Portfolio
+1.01 (+21.54%)
as of Apr 7, 2020

Profile
Ticker Symbol AKER
Exchange NASDAQ
Contact Information
201 GROVE RD
THOROFARE, NJ USA
P: 856-848-8698
CEO/President Christopher C. Schreiber
Earnings at a Glance
Earnings 12/31/19
-1.55
09/30/19
-1.68
06/30/19
-1.44
03/31/19
-1.68
Price Earnings Ratio N/A
EPS Growth N/A
Most Recent Earnings ($) -1.68
Annual EPS ($) -12.95
Business Summary
Akers Biosciences Inc. develops manufactures and supplies rapid point-of-care screening and testing products. The Company's products primarily includes BreathScan(R) BreathScan PRO(R) METRON(R) VIVO(TM) Heparin/PF4 Antibody Serum Panels(R) and Breath Ketone. Akers Biosciences Inc. is based in Thorofare United States.
Industry/Sector SIC-2835 In Vitro & In Vivo Diagnostic Substances
Medical Products